Jazz Pharmaceuticals at SABCS 2026
Dec 8–11, 2026 San Antonio, TX ~11k attendees Website
Jazz Pharmaceuticals brings 2 presentations to SABCS 2026 in San Antonio, and exhibits at Booth 1642. The biopharma company's posters report survival and treatment discontinuation after trastuzumab deruxtecan in HER2-positive metastatic disease.
| Organization | SABCS 2026 Attendance |
|---|---|
Jazz Pharmaceuticals Dublin, Ireland | |
Global biopharma company with medicines for serious diseases, including zanidatamab, a HER2-targeted bispecific antibody studied in breast cancer. | Booth Exhibiting at Booth 1642 Wed, Dec 912:00pm–6:30pmThu, Dec 1012:00pm–6:30pmFri, Dec 1112:00pm–3:00pm Poster Wed Dec 9 5–6:30pm |
Find decision makers at Jazz Pharmaceuticals
Tell us what you sell and we’ll find the people at Jazz Pharmaceuticals most likely to buy it.
- Who to contact
- Their contact info
- What to say
- Free, no sign-up
Not affiliated with the San Antonio Breast Cancer Symposium, UT Health San Antonio or the American Association for Cancer Research. Organization details are derived from SABCS’s published program and exhibitor list. Submit a correction